论文部分内容阅读
目的：分析卡培他滨对乳腺癌患者的临床治疗效果。方法：以我院2008年1月-2010年12月间应用阿霉素化疗的67例乳腺癌患者为对照组，以我院同期应用卡培他滨化疗的69例患者为卡培他滨组，对比两组患者疗效。结果：卡培他滨组治疗后疾病控制率、中位疾病进展时间、生存时间、不良反应发生率等方面均显著优于对照组，两组各项数据经比较差异具有统计学意义，（P＜0．05）。结论：应用卡培他滨治疗乳腺癌，效果显著，安全可靠，值得临床推广应用。“,”objective:to analysis the clinical therapeutic ef ect of breast cancer patients.Methods:from January 2008 to December 2010 between the application of doxorubicin chemo-therapy as the control group,67 cases of breast cancer patients in our hospital during the same period use of capecitabine chemotherapy of 69 patients of capecitabine group,compared two groups of patients with curative ef ect.Results:after treatment capecitabine group,disease control,the median time of disease progression,survival time,incidence of adverse reactions were significant-lybeterthanthatincontrolgroup,twogroupsofdatabycomparingdiferencesstatisticalysignificant,(P <0.05).Conclusion:theuseofcapecitabineforbreastcancer,efective,safeand reliable,worthy of clinical popularization and application.